Stephen Andrew O'Neill bought $248 of OPP
other at RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.. 30 shares at an average of $8.26, traded Oct 17, 2025, filed Oct 20, 2025.
Score components
- +8RoleOther
- 0Trade size$248 at market
- -5Relative to holdingsUnder 1% of holdings (0.5%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.6%, 3m -3.1%, 6m +1.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001398344-25-019371, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 17, 2025 | POpen-market purchase Common Shares of Beneficial Interest | +30 | $8.26 | $248 | 6,178 | Oct 20, 2025 |
Related signals
Other insiders at RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | OPPsell RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. | David Swanson director | $8,428 505 shares | -36% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.